Nicotinic acid adenine dinucleotide sodium

CAS : 104809-30-5

Ref. 3D-NN182765

Informations sur le produit

• Nom: Nicotinic acid adenine dinucleotide sodium
• Synonymes: Deamido-NAD sodium, 1-[5-[[[[5-(6-Aminopurin-9-Yl)-3,4-Dihydroxy-Tetrahydrofuran-2-Yl]Methoxy-Hydroxy-Phosphoryl]Oxy-Hydroxy-Phosphoryl]Oxymethyl]-3,4-Dihydroxy-Tetrahydrofuran-2-Yl]Pyridine-3-Carboxylic Acid, Adenosine 5′-(trihydrogen diphosphate), P′→5′-ester with 3-carboxy-1-β-<span class="text-smallcaps">D</span>-ribofuranosylpyridinium inner salt, monosodium salt, Sodium, Adenosine 5′-(trihydrogen diphosphate), P′→5′-ester with 3-carboxy-1-β-D-ribofuranosylpyridinium inner salt, monosodium salt

Description

Nicotinic acid adenine dinucleotide sodium (NAAD) is a novel anticancer and antiviral agent. NAAD is an analog of nicotinamide adenine dinucleotide (NAD) that has been modified to include a sodium ion. This modification inhibits the synthesis of DNA and RNA, which are required for cell division and replication. It has been shown to inhibit the growth of cancer cells in vitro and in vivo. In addition, NAAD suppresses viral replication by inhibiting protein synthesis in cells infected with HIV-1 or influenza virus. NAAD has also been shown to be a potent inhibitor of ribonucleoside reductase, which converts ribonucleosides into deoxyribonucleosides. This inhibition prevents the conversion of diphosphate nucleotides into monophosphate nucleotides, which are necessary for DNA synthesis.

• Marque: Biosynth

Propriétés chimiques

• Masse moléculaire: 687.4 g/mol
• Formule: C₂₁H₂₆N₆O₁₅P₂•Na
• Degré de pureté: Min. 95%